N′[4-(dipropylamino)benzylidene]-2-hydroxybenzohydrazide is a dynamin GTPase inhibitor that suppresses cancer cell migration and invasion by inhibiting actin polymerization

被引:20
|
作者
Yamada, Hiroshi [1 ,5 ]
Abe, Tadashi [1 ,5 ]
Li, Shun-Ai [2 ]
Tago, Shota [1 ]
Huang, Peng [2 ]
Watanabe, Masami [2 ]
Ikeda, Satoru [3 ]
Ogo, Naohisa [4 ]
Asai, Akira [4 ]
Takei, Kohji [1 ,5 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Kita Ku, Okayama 7008558, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Kita Ku, Okayama 7008558, Japan
[3] Okayama Univ, Grad Sch Hlth Sci, Dept Med Technol, Okayama 7008558, Japan
[4] Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 4228526, Japan
[5] CREST, JST, Kita Ku, Okayama 7008558, Japan
关键词
Dynasore; Dynamin; Actin cytoskeleton; Migration; Invasion; GTPase; CLATHRIN-MEDIATED ENDOCYTOSIS; CRYSTAL-STRUCTURE; BINDING PROTEIN; CYTOSKELETON; PHAGOCYTOSIS; GROWTH; CYTOKINESIS; FILAMENTS; COMPLEX;
D O I
10.1016/j.bbrc.2013.11.118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dynasore, a specific dynamin GTPase inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments. In search for novel dynamin inhibitors that suppress actin dynamics more efficiently, dynasore analogues were screened. N'-14-(dipropylamino)benzylidene]-2-hydroxybenzohydrazide (DBHA) markedly reduced in vitro actin polymerization, and dose-dependently inhibited phosphatidylserine-stimulated dynamin GTPase activity. DBHA significantly suppressed both the recruitment of dynamin 2 to the leading edge in U2OS cells and ruffle formation in H1299 cells. Furthermore, DBHA suppressed both the migration and invasion of H1299 cells by approximately 70%. Furthermore, intratumoral DBHA delivery significantly repressed tumor growth. DBHA was much less cytotoxic than dynasore. These results strongly suggest that DBHA inhibits dynamin-dependent actin polymerization by altering the interactions between dynamin and lipid membranes. DBHA and its derivative may be potential candidates for potent anti-cancer drugs. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:511 / 517
页数:7
相关论文
共 24 条
  • [21] 5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells
    Han, Mengting
    Shen, Jiwei
    Wang, Lijing
    Wang, Yu
    Zhai, Xin
    Li, Yao
    Liu, Meiqiao
    Li, Zengqiang
    Zuo, Daiying
    Wu, Yingliang
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 284 : 24 - 31
  • [22] 5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells (vol 284, pg 24, 2018)
    Han, Mengting
    Shen, Jiwei
    Wang, Lijing
    Wang, Yu
    Zhai, Xin
    Li, Yao
    Liu, Meiqiao
    Gao, Meiqi
    Li, Zengqiang
    Zuo, Daiying
    Wu, Yingliang
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 356
  • [23] Involvement of Matrix Metalloproteinases in the Inhibition of Cell Invasion and Migration Through the Inhibition of NF-κB by the New Synthesized Ethyl 2-[N-p-chlorobenzyl-(2'-methyl)]anilino-4-oxo-4,5-dihydrofuran-3-carboxylate (JOTO1007) in Human Cervical Cancer Ca Ski Cells
    Huang, An-Cheng
    Hsu, Shu-Chun
    Kuo, Chao-Lin
    Liao, Ching-Lung
    Lai, Kuang-Chi
    Lin, Tsung-Ping
    Wu, Shin-Hwar
    Lu, Hsu-Feng
    Tang, Nou-Ying
    Yang, Jai-Sing
    Chung, Jing-Gung
    IN VIVO, 2009, 23 (04): : 613 - 619
  • [24] Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-I] benzenesulfonamide] suppresses nuclear factor-κB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal regulated kinase, and c-Jun N-terminal kinase in human mast cell line cells
    Kim, SJ
    Jeong, HJ
    Choi, IY
    Lee, KM
    Park, RK
    Hong, SH
    Kim, HM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (01): : 27 - 34